A carregar...
Author response to Colle et al
The event of pseudoprogression is rare in patients with MSI-high metastatic colorectal cancer receiving immune checkpoint inhibitors. In this response to the Letter to the Editor by Colle et al, we highlight that the timing of disease re-assessment may influence the incidence of pseudoprogression, w...
Na minha lista:
| Publicado no: | J Immunother Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8231051/ https://ncbi.nlm.nih.gov/pubmed/34162717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-003138 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|